Lloyds Banking Group plc (LLD)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 1.201 |
|---|---|
| 52-week range | 0.978 – 1.378 |
| Return, 1 month / 3 months | −4.2% / −7.8% |
| Return, 1 year / 3 years | +25.8% / +189.9% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 27.1% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 0.18M EUR |
| Dividend yield | 4.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lloyds Banking Group is a British financial services group based in London. It provides retail and commercial banking through brands such as Lloyds Bank, Halifax and Bank of Scotland, offering current accounts, mortgages, savings, loans and credit cards. Its insurance and pensions arm, Scottish Widows, serves personal and workplace customers. The group focuses on customers in the United Kingdom, lending to households and businesses and taking deposits, while also offering investment and protection products.
Lloyds Banking Group plc trades under the code LLD on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lloyds Banking Group plc (LLD) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 1.201 on 23 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 181 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 25.8% and over the last three months it fell 7.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.0% | ||
| From 52-week high | -12.1% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.8% | ||
| 6-month return | 5.8% | ||
| 12-month return, skipping the last month | 31.3% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.18M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.7% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.1% |
|---|---|
| 1 month | −4.2% |
| 3 months | −7.8% |
| 6 months | +5.8% |
| 1 year | +25.8% |
| 3 years | +189.9% |
| 5 years | +166.5% |
Signals
| 50-day / 200-day average | 1.265 / 1.201 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.026 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Aug 2026 | GBP 0.0187 |
| 9 Apr 2026 | GBP 0.0288 |
| 31 Jul 2025 | GBP 0.0145 |
| 10 Apr 2025 | GBP 0.0250 |
| 1 Aug 2024 | GBP 0.0126 |
| 11 Apr 2024 | GBP 0.0218 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.